Revenue for the year to date up 24% on 2011 figures to £81.2 million
Retinal imaging firm Optos has reported a drop in third quarter revenues though sales for the year to date are up 24 per cent on the same period a year ago.
Third quarter revenue was $40.9 million (£26.1 million) compared with £44.1 million (£28.2 million) in the third quarter of last year, a fall of seven per cent.
Revenues for the year to date stand at $127.1 million (£81.2 million), a rise of 24 per cent on the $102.1 million (£65.3 million) reported in the third quarter of 2011.
However, Optos said its latest third quarter figures to June 30 exclude $17 million (£10.8 million) of revenue from advanced orders for its Daytona desktop retinal imaging device, which the company expects to deliver by September 30, 2012.
Optos has already shipped 40 devices ahead of the full sales launch for Daytona on October 1 and has ramped up manufacturing to fill a further 360 outstanding orders it hopes to ship in the current fiscal year.
Sales of Deytona are expected to “deliver positive margin impact” for the full year 2013.
The Dunfermline-based company, which develops imaging technology for eye tests, posted a 77 per cent rise in pre-tax profits to £4.3 million for the first half to March 31 on a 47 per cent rise in turnover to £54 million.
In a third quarter update posted today, Optos said it remains on track to meet market expectations for the full year.
Optos said it has added a total of 114 new customers in the third quarter of 2012 and 278 new customers for the year to date, taking the total to 4,518.
Chief executive, Roy Davis, said: "Our customer base continues to grow, underpinned by demand for all our core products.
“In particular, we are pleased with the market reception to Daytona following its initial launch and our order book continues to grow.
“This quarter has largely been about the manufacturing scale-up of Daytona and ensuring we have sufficient capacity to efficiently fulfil orders.
“We remain on track to deliver against our Daytona order book and look forward to the full sales launch for the product planned for October.”
Shares in Optos rose by 0.6 per cent in early trading today.